Elevation Oncology Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Elevation Oncology Inc
TickerELEV
CIK #0001783032
CUSIP28623U101
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address888 Seventh Ave 12th Floor, New York, NY 10106
Source [EDGAR]
CIK Filing 2011 - 2024
[0001783032] 10-K
[0001783032] 10-Q
[0001783032] 3
[0001783032] 4
[0001783032] 8-K
[0001783032] D
[0001783032] SC 13D
[0001783032] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
ExodusPoint Capital Management LP Elevation Oncology Inc [2023-06-09] 5.8
Integrated Core Strategies US LLC Elevation Oncology Inc [2023-06-08] 5.6
Point72 Asset Management LP Elevation Oncology Inc [2023-05-24] 8.7
Tang Capital Partners LP Elevation Oncology Inc [2023-02-24] 5.8
K2 Healthventures Equity Trust LLC Elevation Oncology Inc [2022-09-30] 6.3
Driehaus Capital Management LLC Elevation Oncology Inc [2022-02-14] 8.54
Aisling Capital IV LP Elevation Oncology Inc [2022-02-14] 12.33
Biotechnology Value Fund L P Elevation Oncology Inc [2022-02-14] 3.5
Qiming US Healthcare GP II LLC Elevation Oncology Inc [2022-02-08] 10.2
Vertex Global HC Fund II PTE Ltd Elevation Oncology Inc [2022-01-18] 0.94
Cormorant Asset Management LP Elevation Oncology Inc [2021-07-09] 1.77
venBio Global Strategic Fund III LP Elevation Oncology Inc [2021-07-09] 11.43
Boxer Capital LLC Elevation Oncology Inc [2021-07-09] 0.0
Form 3/4/5 Filer 2011 - 2024
Ferra Joseph J Jr
Elevation Oncology, Inc.
Dornan David
Jansen Valerie Malyvanh
Clackson Timothy P
Carruthers R Michael
Walsh Colin
Hu Lori
Aisling Capital Partners IV, LP
Aisling Capital IV, LP
Elms Steve
Schiff Andrew N
Aisling Capital Partners IV LLC
Royston Aaron
Adelman Robert J
venBio Global Strategic Fund III, L.P.
Goodman Corey S
venBio Global Strategic GP III LP
Leland Shawn
Qiming U.S. Healthcare Fund II, L.P.
Qiming U.S. Healthcare GP II, LLC
Chen Bihua
Cormorant Private Healthcare Fund III LP
Cormorant Global Healthcare Master Fund, LP
Cormorant Asset Management, LP
Vertex Global HC Fund II Pte. Ltd.
Gaster Richard
venBio Global Strategic GP III Ltd
Form 13F Holdings
Firm Period DFND Voting Shares
Aisling Capital Management LP [2023-03-31] SOLE 2,834,910.0 2,834,910.0
Qiming US Ventures Management LLC [2023-03-31] SOLE 2,370,142.0 2,370,142.0
BVF Inc/IL [2023-03-31] DFND 0.0 2,312,200.0
Cormorant Asset Management LP [2023-03-31] DFND 1,952,032.0 1,952,032.0
venBio Partners LLC [2023-03-31] SOLE 1,866,339.0 1,866,339.0
Tang Capital Management LLC [2023-03-31] OTR 0.0 1,400,000.0
SIO Capital Management LLC [2023-03-31] SOLE 876,611.0 876,611.0
Samsara Biocapital LLC [2023-03-31] SOLE 830,565.0 830,565.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 455,781.0
Walleye Capital LLC [2023-03-31] SOLE 434,448.0 434,448.0
Kennedy Capital Management LLC [2023-03-31] SOLE 149,649.0 149,649.0
Morgan Stanley [2023-03-31] DFND 148,450.0 148,450.0
Geode Capital Management LLC [2023-03-31] DFND 130,380.0 130,380.0
Two Sigma Investments LP [2023-03-31] SOLE 73,958.0 73,958.0
Caxton Corp [2023-03-31] SOLE 68,324.0 68,324.0
Bridgeway Capital Management LLC [2023-03-31] SOLE 56,500.0 56,500.0
Renaissance Technologies LLC [2023-03-31] SOLE 51,500.0 51,500.0
Annandale Capital LLC [2023-03-31] DFND 0.0 50,000.0
State Street Corp [2023-03-31] DFND 42,100.0 42,100.0
BlackRock Inc. [2023-03-31] SOLE 32,751.0 32,751.0
Virtu Financial LLC [2023-03-31] DFND 27,286.0 27,286.0
JPMorgan Chase & Co [2023-03-31] DFND 22,347.0 22,347.0
Northern Trust Corp [2023-03-31] DFND 0.0 14,991.0
Jane Street Group LLC [2023-03-31] DFND 10,449.0 10,449.0
UBS Group AG [2023-03-31] DFND 0.0 100.0
Wells Fargo & Company/MN [2023-03-31] DFND 92.0 92.0
Concourse Financial Group Securities Inc [2023-03-31] SOLE 0.0 0.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com